Clinical trial
Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
NCT00002935 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002935 |
|---|---|
| Title | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer |
| Official title | A Phase II Study of the Safety and Efficacy of Photodynamic Therapy in Carcinoma in Situ of the Esophagus |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | porfimer sodium |
| Enrollment | 30 |
| Start date | Oct 1, 1995 |
| Primary completion | Aug 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Oct 22, 2003 |
| Last update posted | Dec 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: